PharmiWeb

CIFR Expands into California to Investigate Whether Fraud, Probate Failures and Legal Abandonment are Driving Preventable Homelessness

Statewide outreach initiatives across Northern California, Southern California, the Bay Area and the Inland Empire seeks ...
PharmiWeb

Incyte Announces More Than 20 Abstracts Accepted for Presentation at the European Hematology Association (EHA) 2026 Congress

Data from pivotal Phase 3 frontMIND trial evaluating tafasitamab (Monjuvi®/Minjuvi®) in first-line diffuse large b-cell lymphoma (DLBCL) selected for prestigious Plenary Abstracts SessionOral and ...
PharmiWeb

ESTRO 2026 Congress: GE HealthCare to spotlight AI-enabled solutions to advance precision care across radiation therapy and image-guided interventions

The company will showcase the latest iRT solution, MIM software innovations, and BK Medical technology – advancing speed, connectivity, and personalized medicine across the cancer care pathway.CHICAGO ...
PharmiWeb

Moderna Recognized by TIME as One of the World's Most Impactful Companies

CAMBRIDGE, MA / ACCESS Newswire / May 12, 2026 / Moderna, Inc. (NASDAQ:MRNA) today announced it was ranked no. 1 on TIME's 2026 list of the World's Most Impactful Companies. The recognition highlights ...
PharmiWeb

Tenon(R) Medical Reports First Quarter 2026 Financial Results

First Quarter 2026 Revenue of $1.4 Million, an Increase of Approximately 90% Compared to Prior Year ~~ First Quarter Gross ...
PharmiWeb

JAMS Launches ADR Technology Industry Group

The group addresses the growing complexity and volume of tech-related disputesIRVINE, Calif.--(BUSINESS WIRE)--JAMS, the premier provider of alternative dispute resolution (ADR) services worldwide, ...
PharmiWeb

Skylark Bio to Present New Preclinical Data for its Pendrin Gene Therapy Program for Hearing Loss at ASGCT 2026

Data demonstrate dose‑dependent hearing rescue across multiple mouse modelsCAMBRIDGE, Mass.--(BUSINESS ...
PharmiWeb

AGC Biologics Joins Orphan Therapeutics Accelerator’s Clinical Development Network as a Manufacturing Partner to Advance Cell and Gene Therapies for Ultra-Rare Diseases

Collaboration brings AGC Biologics’ advanced therapy expertise and global footprint to OTXL’s network, supporting a sustainable path from clinical development to commercial access for therapies ...
PharmiWeb

Poolbeg Pharma plc - POLB 001 cancer immunotherapy-induced CRS patent granted in Canada

Further strengthening of Poolbeg's global intellectual property portfolio11 May 2026 - Poolbeg Pharma (AIM: POLB, 'Poolbeg' or the 'Company'), a clinical-stage biopharmaceutical company with a core ...
PharmiWeb

Vistagen Announces Preliminary Positive Data in Ongoing Open-Label Extension Portion of PALISADE-3 Phase 3 Study of Fasedienol for the Acute Treatment of Social Anxiety Disorder

Fasedienol nasal spray has been well-tolerated in patients with social anxiety disorder with no new drug-related safety findings after as-needed use in daily life for up to 12 monthsClinically ...
PharmiWeb

bioAffinity Technologies Reports Record Monthly CyPath® Lung Unit Sales and Significant Year-Over-Year Growth in April 2026

CyPath® Lung unit sales in April increased nearly 300% compared to April 2025Increasing unit sales for CyPath® Lung continues first quarter 2026 trend of accelerating adoption and clinical ...
PharmiWeb

Medisca and dsm–firmenich Partner to Expand Access to Pharmaceutical-Grade Vitamin APIs for U.S. Compounding Market

Medisca, a global leader in personalized pharmaceutical medicine, has entered into a strategic partnership with dsm–firmenich, a leading ingredient manufacturer serving regulated pharmaceutical ...